National Health Investors
NHI

$82.56

0.3%

Market Cap: $3.59B

About: National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments i.e. Real Estate Investments and Senior Housing Operating Portfolio. The Real Estate Investments segment consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived from rental income, mortgage and other notes receivable interest income, and resident fees and services.

Employees: 26

Financials Real Estate Investment Trusts

0

Funds holding %

of 6,710 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

35% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 26

11% more capital invested

Capital invested by funds: $1.68B [Q1] → $1.86B (+$183M) [Q2]

4% more funds holding

Funds holding: 216 [Q1] → 225 (+9) [Q2]

1.74% more ownership

Funds ownership: 61.46% [Q1] → 63.21% (+1.74%) [Q2]

3% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 76

0% more funds holding in top 10

Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]

22% less call options, than puts

Call options by funds: $724K | Put options by funds: $934K

See Fund Rankings

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$65

21%

downside

Avg. target

$72

13%

downside

High target

$78

6%

downside

2 analyst ratings

0 positive

0%

2 neutral

100%

0 negative

0%

Truist Securities Michael Lewis 84% 1-year accuracy 37 / 44 met price target	6%downside $78	Hold Maintained	30 Aug 2024
Truist Securities Michael Lewis 84% 1-year accuracy 37 / 44 met price target	21%downside $65	Hold Maintained	26 Jun 2024

See Analyst Rankings

Financial journalist opinion

Based on 6 articles about NHI published over the past 30 days

Zacks Investment Research

ESRT vs. NHI: Which Stock Should Value Investors Buy Now?

Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both Empire State Realty Trust (ESRT) and National Health Investors (NHI). But which of these two stocks offers value investors a better bang for their buck right now?

ESRT vs. NHI: Which Stock Should Value Investors Buy Now?

Zacks Investment Research

National Health Investors (NHI) is a Great Momentum Stock: Should You Buy?

Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.

National Health Investors (NHI) is a Great Momentum Stock: Should You Buy?

Four REIT stocks pass a strict quality screen, with dividend yields up to 6.19%

Investors can never predict the exact timing of interest-rate cuts, but many expect the Federal Open Market Committee to begin reducing the target range for the federal-funds rate on Sept. 18, following its next policy meeting.

Four REIT stocks pass a strict quality screen, with dividend yields up to 6.19%

Office REITs find an open door in the bond market

Top owners of high-quality office properties were among a batch of public real-estate investment trusts that raised nearly $2.5 billion in debt and equity in the past week.

Office REITs find an open door in the bond market

NHI Announces Pricing of Upsized Public Offering of Common Stock

MURFREESBORO, TN / ACCESSWIRE / August 14, 2024 / National Health Investors, Inc. (NYSE:NHI) (the "Company") announced today the pricing of an underwritten public offering of 2,400,000 shares of its common stock at a public offering price of $71.25 per share, all of which will be offered on a forward basis through the forward purchasers (as defined below) or their respective affiliates in connection with the forward sale agreements described below. The underwriters were also granted a 30-day option to purchase up to an additional 360,000 shares of the Company's common stock from the forward purchasers.

NHI Announces Pricing of Upsized Public Offering of Common Stock

NHI Announces Public Offering Of Common Stock

MURFREESBORO, TN / ACCESSWIRE / August 14, 2024 / National Health Investors, Inc. (NYSE:NHI) (the "Company") announced today that it has commenced an underwritten public offering of 2,000,000 shares of its common stock, all of which will be offered on a forward basis through the forward purchasers (as defined below) or their respective affiliates in connection with the forward sale agreements described below. The underwriters of the offering also expect to be granted a 30-day option to purchase up to an additional 300,000 shares of the Company's common stock from the forward purchasers.

NHI Announces Public Offering Of Common Stock

National Health Investors, Inc. (NHI) Q2 2024 Earnings Call Transcript

National Health Investors, Inc. (NYSE:NHI ) Q2 2024 Earnings Conference Call August 7, 2024 11:00 AM ET Company Participants Dana Hambly - Director of IR Eric Mendelsohn - President and CEO Kevin Pascoe - Chief Investment Officer John Spaid - Chief Financial Officer Conference Call Participants Robin Haneland - BMO Capital Markets Rich Anderson - Wedbush John Kilichowski - Wells Fargo Austin Wurschmidt - KeyBanc Capital Markets Operator Good morning, everyone, and welcome to the National Health Investors Second Quarter 2024 Earnings Webcast and Conference Call. At this time, all participants have been placed on a listen-only mode, and we will open the floor for your questions and comments after the presentation.

National Health Investors, Inc. (NHI) Q2 2024 Earnings Call Transcript

Zacks Investment Research

National Health Investors (NHI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for National Health Investors (NHI) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

National Health Investors (NHI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research

National Health Investors (NHI) Q2 FFO and Revenues Beat Estimates

National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.18 per share, beating the Zacks Consensus Estimate of $1.10 per share. This compares to FFO of $1.06 per share a year ago.

National Health Investors (NHI) Q2 FFO and Revenues Beat Estimates

NHI Announces Third Quarter 2024 Dividend

MURFREESBORO, TN / ACCESSWIRE / August 6, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its third quarter dividend of $0.90 per common share on November 1, 2024 to stockholders of record as of September 27, 2024. About NHI Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.

NHI Announces Third Quarter 2024 Dividend

See News Rankings